Access to medicines – September 2018

HTA

Response to HTA proposal
At the beginning of August, we published our response to the HTA proposal of the European Commission (see HERE). This response was also emailed to key actors in the European Commission and the European Parliament as well as to the health attachés of the Permanent Representations.

HTA Stakeholder Group
This group is at the moment fairly quiet due to the fact that there is no upcoming meeting of the HTA Stakeholder Network.

Biosimilars

Biosimilar medicines
Commission event on Biosimilar Medicines – September 2018
PH and SK will attended the event on 14 September. The President of the Spanish Hospital Pharmacy Associations participates as a speaker. More information will be shared during the Board meeting.

ESNO – biosimilar guide for nurses
The switch management guide of ESNO was launched (see HERE) during an event in Brussels. It seems that no further efforts to disseminate this guide were made since ESNO is concentrating on the launch of other policy publications (position on vaccination, position on AMR and survey results on shortages). As discussed during the Board meeting in April, the Board still needs to take a decision as to whether EAHP would like to endorse ESNO’s switch management guide or not.

Procurement

Given the importance of the topic for our HPs, the Board should discuss if the position paper should be disseminated further. So far, we have only promoted it via our social media channels, our website and mentioned it to other associations in an informal setting during policy events. In case further dissemination is envisioned, meetings with key stakeholders could be set up.